Myelodysplastic syndrome: review of the cytogenetic and molecular data
- 3 December 2001
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 40 (3) , 229-238
- https://doi.org/10.1016/s1040-8428(01)00101-9
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cytogenetic Abnormalities in Primary Myelodysplastic Syndrome Are Highly Predictive of Outcome After Allogeneic Bone Marrow TransplantationBlood, 1998
- The 5q-syndromeBlood, 1994
- Molecular Mapping of Uncharacteristically Small 5q Deletions in Two Patients with the 5q- Syndrome: Delineation of the Critical Region on 5q and Identification of a 5q- BreakpointGenomics, 1994
- Familial MDS with 5q — abnormalityBritish Journal of Haematology, 1993
- Anti-Oncogenic and Oncogenic Potentials of Interferon Regulatory Factors-1 and -2Science, 1993
- Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monosomy 7Genomics, 1992
- Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disordersBlood, 1992
- Colony-stimulating factor-1 receptorBlood, 1990
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982
- Distinct haematological disorder with deletion of long arm of No. 5 chromosomeNature, 1974